iShares Genomics Immunology and Healthcare ETF(IDNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IDNA iShares Genomics Immunology and Healthcare ETF

已收盘 07-08 16:00:00 EDT

34.25

-0.47

-1.35%

盘后34.16

-0.09-0.26%

19:07 EDT

最高34.43	最低33.74	成交量9.08万
今开34.23	昨收34.72	日振幅1.99%
总市值1.99亿	流通市值1.99亿	总股本580.00万
成交额309.32万	换手率1.57%	流通股本580.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":34.25,"timestamp":1783540800000,"preClose":34.72,"halted":0,"volume":90815,"hourTrading":{"tag":"盘后","latestPrice":34.16,"preClose":34.25,"latestTime":"19:07 EDT","volume":256,"amount":8782.3,"timestamp":1783552055612,"change":-0.09,"changeRate":-0.002628,"amplitude":0},"delay":0,"changeRate":-0.013536866359446972,"floatShares":5800000,"shares":5800000,"eps":0,"marketStatus":"已收盘","change":-0.47,"latestTime":"07-08 16:00:00 EDT","open":34.23,"high":34.43,"low":33.74,"amount":3093188.5056900005,"amplitude":0.019873,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783584000000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":34.72,"sharesOutstanding":5100000,"nav":34.588948,"aum":200615898.4,"dividendRate":0.008201,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.57,"preClose":34.72,"latestTime":"09:14 EDT","volume":310,"amount":10515.70096,"timestamp":1783516491913,"change":-0.15,"changeRate":-0.00432,"amplitude":0.019297},"postHourTrading":{"tag":"盘后","latestPrice":34.16,"preClose":34.25,"latestTime":"19:07 EDT","volume":256,"amount":8782.3,"timestamp":1783552055612,"change":-0.09,"changeRate":-0.002628,"amplitude":0},"volumeRatio":1.057976,"impliedVol":0.1668,"impliedVolPercentile":0.4223},"requestUrl":"/m/hq/s/IDNA","defaultTab":"news","newsList":[{"id":"2649299398","title":"大摩解读福泰制药百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649299398?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1585245621.USD","LU0823416689.USD","IE0009355771.USD","LU2133065610.SGD","LU0210528500.USD","LU0109394709.USD","IAI","LU0267386448.USD","KBWB","LU1720051108.HKD","LU0432979614.USD","LU2362541273.HKD","LU2236285917.USD","LU1791710400.SGD","IBB","LU0058720904.USD","IE00BZ9MQY76.HKD","LU2456880835.USD","PBE","LU1674673691.USD","IDNA","IE0002141913.USD","SG9999001176.USD","LU0528227936.USD","IE00B19Z3581.USD","LU1732799900.SGD","IE0002270589.USD","BBH","BK4139","LU0053666078.USD","LU2111349929.HKD","LU2237438978.USD","LU0882574139.USD","LU2089284900.SGD","IBBQ","LU0390134368.USD","BK4588","BK4533","LU0079474960.USD","LU1363072403.SGD","LU1244550221.USD","BK4581","BIB","LU2487616109.SGD","LU0098860793.USD","VRTX","IE00B19Z9P08.USD","LU2362540622.SGD","LU1720051017.SGD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649939579","title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649939579","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649939579?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:40","pubTimestamp":1783510856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1430594728.SGD","LU2347655156.SGD","LU1074936037.SGD","SG9999001176.USD","LU0053666078.USD","LU1244550221.USD","LU0795875086.SGD","LU1585245621.USD","PBE","LU2237438978.USD","SG9999013999.USD","IE00B19Z9Z06.USD","IDNA","LU1548497426.USD","LU0314104364.USD","LU0061475181.USD","BK4567","LU0882574139.USD","IBB","BK4127","LU2362540622.SGD","IE00B19Z3581.USD","LU1720051017.SGD","LU0795875169.SGD","BK4139","KBWB","SG9999001176.SGD","LU1244550577.SGD","LU0006306889.USD","LU0823416689.USD","LU1674673428.USD","BBH","IE00B19Z3B42.SGD","LU0417517546.SGD","LU2089283258.USD","LU0079474960.USD","LU2271345857.HKD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","BIB","IBBQ","VRTX","LU2487616109.SGD","LU2417539215.USD","LU2462157665.USD","IAI","LU2362541273.HKD","LU1668664300.SGD","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上调福泰制药目标价至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649969921?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2417539215.USD","VRTX","LU1778281490.HKD","IE00B2B36J28.USD","LU0029864427.USD","UDN","LU1093756168.USD","BK4567","SG9999001176.USD","BIB","BK4207","IE00B894F039.SGD","SGXZ57979304.SGD","BK4532","LU2456880835.USD","LU0708994859.HKD","IDNA","IE0009355771.USD","BK4139","LU0128525929.USD","RY","LU1069344957.HKD","LU0320765992.SGD","LU2462157665.USD","LU0823416689.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0234570918.USD","IE00B4R5TH58.HKD","LU1267930573.SGD","PBE","LU0417517546.SGD","LU2324357040.USD","LU0058720904.USD","UUP","SG9999013999.USD","BBH","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD","BK4533","GSIB","IBBQ","IE00B19Z9P08.USD","LU1093756325.SGD","LU2237438978.USD","LU2362540622.SGD","LU0310800379.SGD","IBB","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111378876","title":"Vera Therapeutics股价飙升：肾病新药获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111378876","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111378876?lang=zh_cn&edition=full","pubTime":"2026-07-08 02:47","pubTimestamp":1783450047,"startTime":"0","endTime":"0","summary":"周二，Vera Therapeutics, Inc.的股价上涨约8%，此前美国食品药品监督管理局批准了其用于治疗IgA肾病的药物。这款名为Trutakna的药物通过阻断两种蛋白质来发挥作用，这两种蛋白质会促使免疫系统产生抗体，这些抗体在肾脏中积聚并造成损伤。这是美国首个获批同时靶向这两种蛋白质的药物，尽管已有其他几种药物治疗该疾病。福泰制药正在研发一种同样能阻断这两种蛋白质的类似药物，FDA预计将在今年晚些时候对此做出裁决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU2362540622.SGD","LU0058720904.USD","LU0417517546.SGD","IE0009355771.USD","LU0823416689.USD","LU2362541273.HKD","SGXZ57979304.SGD","IBBQ","BK4533","LU2456880835.USD","IE00B19Z3581.USD","LU2362541513.USD","SG9999013999.USD","LU0289739699.SGD","BK4539","IE00B2B36J28.USD","LU1093756325.SGD","SG9999001176.SGD","IE0002270589.USD","LU1430594728.SGD","IDNA","BIB","LU1674673691.USD","LU2462157665.USD","LABU","LU2237438978.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD","LU1069344957.HKD","LU1585245621.USD","IE00BJT1NW94.SGD","VERA","LU0432979614.USD","BK4532","IE0002141913.USD","LU1035775433.USD","LU1093756168.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","LU1778281490.HKD","BK4567","PBE","BK4588","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU0256863811.USD","LU0061475181.USD","IBB","BK4585","LU1674673428.USD","VRTX","LU0109394709.USD","LU0234570918.USD","BBH","LU2417539215.USD","BK4139","LU0320765992.SGD","LU2324357040.USD","LU0079474960.USD","SG9999001176.USD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175603747","title":"欧洲药品管理局启动分阶段审评，加速评估Revolution Medicines的Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=1175603747","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175603747?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:30","pubTimestamp":1783431047,"startTime":"0","endTime":"0","summary":"欧洲药品管理局已决定通过分阶段审评程序，加快对Revolution Medicines, Inc.（股票简称：RVMD）旗下在研药物Daraxonrasib的评估进程。此举旨在缩短该潜在疗法的审评时间，使其能更早惠及患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0320765992.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","CANC","IE00B4R5TH58.HKD","BK4139","IDNA","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","RVMD","LU0109394709.USD","IE00B2B36J28.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100亿美元砸出史上最大收购：福泰制药(VRTX.US)溢价100%收购Crinetics(CRNX.US)，杀入内分泌赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649708736?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1035775433.USD","LU0058720904.USD","BBH","PBE","LU1430594728.SGD","LU0079474960.USD","LU2417539215.USD","LU1778281490.HKD","LU0320765992.SGD","LU0889565916.HKD","LU2362540622.SGD","IBB","LU0109394709.USD","BIB","LU0432979614.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","LU2237438978.USD","BK4139","IE00B2B36J28.USD","LU0061475181.USD","IE00BJT1NW94.SGD","LU2362541273.HKD","IDNA","SG9999001176.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0823416689.USD","LU1674673691.USD","CRNX","LU2324357040.USD","BK4585","BK4588","IE00B19Z3581.USD","LU0289739699.SGD","LU0256863811.USD","LU1093756168.USD","LU1093756325.SGD","SG9999001176.SGD","LU0417517546.SGD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1585245621.USD","BK4007","VRTX","IBBQ","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","BK4533","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情况下交易终止，Crinetics Pharmaceuticals或需向福泰制药支付3.5047亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159544198?lang=zh_cn&edition=full","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE00B19Z3B42.SGD","LU0432979614.USD","LU0889565916.HKD","VRTX","LU0079474960.USD","CRNX","LU0256863811.USD","LU1778281490.HKD","LU2236285917.USD","LU2417539215.USD","BK4007","IDNA","LU1585245621.USD","IE00BJT1NW94.SGD","BK4139","LU1069344957.HKD","LU1674673428.USD","LU2362541513.USD","LU2456880835.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1093756325.SGD","LU2362540622.SGD","LU2237438978.USD","PBE","LU0109394709.USD","SG9999013999.USD","LU0320765992.SGD","LU1035775433.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0417517546.SGD","LU0823416689.USD","BK4533","BK4567","LU0061475181.USD","IE0002270589.USD","IE0002141913.USD","BK4532","IE00B2B36J28.USD","IE00B19Z9P08.USD","SG9999001176.USD","BIB","LU2362541273.HKD","IE00B894F039.SGD","IBBQ","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","BBH","IE00BZ9MQY76.HKD","IE0009355771.USD","LU1674673691.USD","LU1430594728.SGD","BK4585","LU1093756168.USD","IBB","LU0058720904.USD","LU2462157665.USD","SG9999001176.SGD","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物制药公司Crinetics盘后涨超100%福泰制药将以85美元/股收购公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649679149?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B19Z9P08.USD","IE00BJT1NW94.SGD","BK4532","SG9999001176.USD","LU2362541513.USD","BBH","IE0002141913.USD","IE00B19Z3581.USD","BBP","LU0289739699.SGD","PBE","BIB","BK4588","BK4567","LU2417539215.USD","UUP","SGXZ57979304.SGD","LU0823416689.USD","LU1035775433.USD","IE00BFTCPJ56.SGD","MRNX","LU1093756168.USD","LU0320765992.SGD","BK4585","VRTX","BK4139","IBB","IE00B19Z9Z06.USD","BK4533","LU1093756325.SGD","MRNY","UDN","LU2324357040.USD","LU1778281490.HKD","LU1585245621.USD","SG9999013999.USD","LU2236285917.USD","LU2456880835.USD","LU2462157665.USD","LU2237438978.USD","LU1674673428.USD","IDNA","LU2362541273.HKD","LU0079474960.USD","LU1674673691.USD","IE00BJJMRZ35.SGD","LU2362540622.SGD","LU0061475181.USD","IE00B2B36J28.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics与福泰制药交易预计2029年提升后者非GAAP运营收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127833937?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0432979614.USD","LU2324357040.USD","IBBQ","BK4532","IE0002141913.USD","LU1093756325.SGD","IE0009355771.USD","LU1035775433.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","SG9999013999.USD","IE00B894F039.SGD","LU1093756168.USD","LU1778281490.HKD","VRTX","IE00BJJMRZ35.SGD","LU0109394709.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU2236285917.USD","BK4139","IE0002270589.USD","LU1674673428.USD","LU0058720904.USD","LU2362541513.USD","LU2417539215.USD","IE00B19Z3B42.SGD","BK4533","BK4567","LU2362541273.HKD","LU0079474960.USD","LU0256863811.USD","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU1674673691.USD","SG9999001176.USD","LU2462157665.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU0234570918.USD","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU2362540622.SGD","SG9999001176.SGD","IBB","BBH","LU2456880835.USD","LU1585245621.USD","BIB","LU0417517546.SGD","LU0289739699.SGD","LU2237438978.USD","IE00B19Z9Z06.USD","LU0061475181.USD","BK4585","PBE","IDNA","LU0823416689.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4588","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融资获美国银行与摩根士丹利的45亿美元全额承诺过桥贷款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179291339?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU1674673428.USD","BK4533","LU2362540622.SGD","LU1430594728.SGD","LU2324357040.USD","IE00B4R5TH58.HKD","LU0432979614.USD","LU2462157665.USD","LU2362541513.USD","LU0320765992.SGD","IE00B19Z3581.USD","LU2237438978.USD","LU0823416689.USD","IE00B19Z9P08.USD","LU0234570918.USD","IE00BFTCPJ56.SGD","IBB","IE00BZ9MQY76.HKD","IBBQ","SG9999001176.USD","LU1093756168.USD","IE0009355771.USD","LU0079474960.USD","LU1093756325.SGD","LU2236285917.USD","SG9999013999.USD","BK4585","SGXZ57979304.SGD","BK4007","LU0058720904.USD","BK4588","BBH","LU2456880835.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","BK4139","LU0417517546.SGD","LU0289739699.SGD","PBE","IE0002141913.USD","CRNX","IE0002270589.USD","IE00B894F039.SGD","LU0061475181.USD","LU0889565916.HKD","LU1778281490.HKD","LU2362541273.HKD","BK4532","LU1585245621.USD","LU2417539215.USD","LU1674673691.USD","BIB","BK4567","LU1035775433.USD","LU0256863811.USD","VRTX","LU0109394709.USD","IDNA","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰制药就囊性纤维化疗法Alyftrek与泛加拿大药品联盟签署意向书","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154393441?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤，旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","SG9999001176.USD","LU0823416689.USD","LU2237438978.USD","LU2462157665.USD","IBB","IE00B19Z9P08.USD","BK4139","LU1035775433.USD","PBE","BK4585","IBBQ","LU1778281490.HKD","IE00B4R5TH58.HKD","LU2324357040.USD","SG9999001176.SGD","BK4588","LU0234570918.USD","LU0109394709.USD","LU0058720904.USD","IE00B894F039.SGD","IE00B2B36J28.USD","LU0889565916.HKD","LU0417517546.SGD","IE00B19Z3B42.SGD","VRTX","LU0079474960.USD","LU0256863811.USD","LU1430594728.SGD","LU2362540622.SGD","LU2362541513.USD","LU2362541273.HKD","LU1585245621.USD","BK4567","BK4532","LU0320765992.SGD","LU1069344957.HKD","LU1674673428.USD","SG9999013999.USD","IE00B19Z3581.USD","LU2236285917.USD","LU2456880835.USD","BBH","IE00BJT1NW94.SGD","LU2417539215.USD","IE0002270589.USD","IE00B19Z9Z06.USD","IDNA","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","IE0002141913.USD","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1093756325.SGD","IE0009355771.USD","BIB","LU0061475181.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649858622","title":"Incyte(INCY)以12.5亿美元完成收购Vega Therapeutics 拓宽血液学管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2649858622","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649858622?lang=zh_cn&edition=full","pubTime":"2026-07-06 21:19","pubTimestamp":1783343950,"startTime":"0","endTime":"0","summary":"根据双方此前达成的股票购买协议，Incyte已支付12.5亿美元的预付款，收购了Vega Therapeutics的全部发行在外股份。此外，Star Therapeutics未来还有权获得最高达7.5亿美元的商业销售里程碑付款。通过本次收购，Incyte成功将Vega的核心资产——创新单克隆抗体VGA039收入囊中。目前，该药物正在全球开展一项名为VIVID-6的单臂交叉3期临床试验，以评估其在各类血管性血友病患者中的安全性和有效性。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NTkwMTRiMmRhYjljZTk4MGRjMGViZTQ1NDI1NzQxMTc4OQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NTkwMTRiMmRhYjljZTk4MGRjMGViZTQ1NDI1NzQxMTc4OQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302236","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IDNA","LENZ","BK4139","BK4550","BK4585","INCY","BK4588","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197736511","title":"Evercore ISI将Twist Bioscience评级从“跑赢大盘”下调至“与大市持平”，目标价大幅上调至102美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197736511","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197736511?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:12","pubTimestamp":1783332778,"startTime":"0","endTime":"0","summary":"投行Evercore ISI调整了对生物科技公司Twist Bioscience Corp（TWST）的评级。该机构将Twist Bioscience的股票评级从“跑赢大盘”（Outperform）下调至“与大市持平”（In Line）。与此同时，分析师大幅上调了该股的目标价，从此前的66美元提升至102美元。这一调整反映了投行在评估公司前景时，对短期表现预期与长期价值潜力进行了重新权衡。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","BK4139","BK4585","ARKG","BK4588","GNOM","WDNA","TWST"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0287},{"period":"1month","weight":0.1915},{"period":"3month","weight":0.1762},{"period":"6month","weight":0.2616},{"period":"1year","weight":0.6814},{"period":"ytd","weight":0.3257}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0138},{"period":"3month","weight":0.1061},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.2047},{"period":"ytd","weight":0.0965}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.000583},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.001958},{"month":3,"riseRate":0,"avgChangeRate":-0.043509},{"month":4,"riseRate":0.714286,"avgChangeRate":0.010336},{"month":5,"riseRate":0.571429,"avgChangeRate":0.017257},{"month":6,"riseRate":0.714286,"avgChangeRate":0.039341},{"month":7,"riseRate":0.75,"avgChangeRate":0.027924},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.00637},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.034801},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.001378},{"month":11,"riseRate":0.857143,"avgChangeRate":0.076951},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.021129}],"exchange":"ARCA","name":"iShares Genomics Immunology and Healthcare ETF","nameEN":"iShares Genomics Immunology and Healthcare ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iShares Genomics Immunology and Healthcare ETF(IDNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iShares Genomics Immunology and Healthcare ETF(IDNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iShares Genomics Immunology and Healthcare ETF,IDNA,iShares Genomics Immunology and Healthcare ETF股票,iShares Genomics Immunology and Healthcare ETF股票老虎,iShares Genomics Immunology and Healthcare ETF股票老虎国际,iShares Genomics Immunology and Healthcare ETF行情,iShares Genomics Immunology and Healthcare ETF股票行情,iShares Genomics Immunology and Healthcare ETF股价,iShares Genomics Immunology and Healthcare ETF股市,iShares Genomics Immunology and Healthcare ETF股票价格,iShares Genomics Immunology and Healthcare ETF股票交易,iShares Genomics Immunology and Healthcare ETF股票购买,iShares Genomics Immunology and Healthcare ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iShares Genomics Immunology and Healthcare ETF(IDNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iShares Genomics Immunology and Healthcare ETF(IDNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}